USA Markit Composite PMI for Aug 55.400 vs 59.900 prior reading.
Related Posts
Second Sight Medical Products, Inc. Announces Shareholder Approval For Proposed Merger With Nano Precision Medical, Inc. And Other Results Of 2022 Annual Meeting; Co. To Change Name To Vivani Medical, Inc.
Second Sight Medical Products, Inc. (NASDAQ:EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful
Deutsche Bank Maintains Hold on Freeport-McMoRan, Lowers Price Target to $30
Deutsche Bank analyst Abhi Agarwal maintains Freeport-McMoRan (NYSE:FCX) with a Hold and lowers the price target from $35 to $30.
Vaxcyte Completes Enrollment Of Phase 2 Portion Of Phase 1/2 Clinical Proof-Of-Concept Study Evaluating Safety, Tolerability And Immunogenicity Of VAX-24 In Adults
Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults
-- Company Expects to Announce Topline Results from the